Tag: <span>Acute Graft-versus-Host Disease (GvHD)</span>

Home / Acute Graft-versus-Host Disease (GvHD)
Post

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

Principal investigator, Dr. Leslie Kean, associate director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s, leads several research projects to develop novel approaches to predicting and preventing graft-versus-host disease.    Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH)...